Home
Conditions
Pancreatic Adenocarcinoma

Clinical trial condition

Pancreatic Adenocarcinoma

Explore clinical trials studying Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

205 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma trial results

Not yet recruiting

GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy

NCT07796997

Conditions: Digestive System Diseases, Digestive System Neoplasms, Distal Cholangiocarcinoma, +15 more
Locations: University of Illinois Cancer Center Chicago, Illinois, United States

View Trial Details

Not yet recruiting

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

NCT07583771

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +21 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Not yet recruiting

A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors

NCT07566897

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations: Fondazione Policlinico Gemelli Unità di Fase 1: Unità di Farmacologia Clinica Roma, Italy

View Trial Details

Not yet recruiting

Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency

NCT07565155

Conditions: Homologous Recombination Deficiency, Pancreatic Adenocarcinoma
Locations: University of Miami Miami, Florida, United States

View Trial Details

Not yet recruiting

Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy

NCT07547033

Conditions: Pancreatic Adenocarcinoma, Pancreatic Head Cancer
Locations: CHU Amiens Amiens, France

CHU Angers Angers, France

CHU Besançon Besançon, France

Hôpital Haut Lévêque Bordeaux, France

View all 23 locations

View Trial Details

Not yet recruiting

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

NCT06217666

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Not yet recruiting

Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs

NCT07093593

Conditions: Cervical Cancers, Endometrial Cancer, Endometrial Neoplasms, +16 more
Locations: Not specified

View Trial Details

Not yet recruiting

Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas

NCT06776146

Conditions: Disease, Pancreatic Adenocarcinoma, Pathologic Processes, +1 more
Locations: CHU Bordeaux Pessac, France

View Trial Details

Not yet recruiting

68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma

NCT06911021

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations: Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland

View Trial Details

Not yet recruiting

Pilot Study of EUS-Guided Radiofrequency and FOLFIRINOX in Advanced Pancreatic Cancer (RadioFAP )

NCT06743386

Conditions: Pancreatic Adenocarcinoma
Locations: Not specified

View Trial Details

Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma trial results

Related conditions